ResMed Analysts Increase Their Forecasts After Strong Q2 Earnings

Resmed (RMD) reported stronger-than-anticipated second-quarter results, with earnings of $2.55 per share exceeding the $2.46 consensus and sales of $1.348 billion surpassing the $1.321 billion estimate. This performance, attributed by the CEO to robust demand for its devices, propelled RMD shares up 2.1% and prompted multiple analysts, including UBS and Keybanc, to raise their price targets, signaling positive market and analyst sentiment.

Analysis

Resmed Inc. (RMD) delivered a robust second-quarter performance, outperforming consensus estimates on both revenue and earnings. The company reported quarterly sales of $1.348 billion against a $1.321 billion forecast and an EPS of $2.55, which surpassed the analyst expectation of $2.46. According to CEO Mick Farrell, this momentum is attributable to strong global demand for the company's core sleep and breathing health devices and its growing digital health platform. The positive results triggered a 2.1% rise in RMD's share price to $277.70 and prompted a wave of positive analyst revisions. Notably, at least six separate analysts raised their price targets, with new targets ranging from $270 to $325. While ratings from firms like UBS, Keybanc, and RBC remain bullish (Buy/Outperform), others such as Piper Sandler and Stifel maintained neutral-equivalent ratings (Neutral/Hold), indicating a consensus on improved fundamentals but a divergence on valuation and future upside from the current price.

Key Decisions for Investors

• Given the strong top-and-bottom-line beat and upward price target revisions from multiple analysts, investors may view this as a confirmation of RMD's fundamental strength and market leadership.
• Investors should weigh the bullish price targets from firms like UBS ($325) against the more cautious Hold/Neutral ratings from others whose targets ($270) are below the current trading price, suggesting potential valuation concerns.
• It is prudent to monitor whether the 'robust global demand' cited by the CEO can be sustained in subsequent quarters, as this is the core driver of the current outperformance and positive sentiment.